Microbot Medical Inc buy The Goldman Sachs Group, Inc.
Start price
24.01.24
/
50%
€1.17
Target price
24.01.25
€5.51
Performance (%)
64.36%
End price
25.01.25
€1.92
Summary
This prediction ended on 25.01.25 with a price of €1.92. With a performance of 64.36% the BUY prediction by The_Goldman_Sachs_Gr was a big success. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Microbot Medical Inc | -3.871% | -3.871% | -49.526% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Microbot Medical Inc diskutieren
Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat
In the thread Trading Microbot Medical Inc
Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten